CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Samsung Biologics Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Samsung Biologics Co Ltd
300, Songdo bio-daero, Yeonsu-gu
Phone: +82 324553114p:+82 324553114 INCHEON, 21987  South Korea Ticker: 207940207940
Business Summary
Samsung Biologics Co Ltd is a Korea-based company primarily engaged in the production of antibody drugs. The Company operates through two segments. The Contract Development and Manufacturing Organization (CDMO) segment primarily provides biopharmaceutical contract manufacturing and cell line development services. The Biopharmaceutical Development and Commercialization segment primarily engages in the development and commercialization of biosimilars.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202412/31/2024Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Director JohnRim 63 3/20/2023 3/20/2020
Vice President, Director Seung HoYoo 56 3/14/2025 12/6/2023
Vice President, Director GyunNoh 61 3/17/2023 1/1/2021
11 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Samsung Bioepis Co,.Ltd. 76, Songdogyoyuk-ro Incheon Yeonsu-gu South Korea

Business Names
Business Name
207940
Samsung Bioepis Co,.Ltd.

General Information
Number of Employees: 2,587 (As of 12/31/2019)
Outstanding Shares: 71,174,000 (As of 12/31/2024)
Shareholders: 124,028
Stock Exchange: KRX
Fax Number: +82 324553825


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 19, 2025